Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
133.11
Dollar change
+2.05
Percentage change
1.56
%
IndexS&P 500 P/E17.78 EPS (ttm)7.49 Insider Own0.90% Shs Outstand111.00M Perf Week3.32%
Market Cap14.74B Forward P/E14.14 EPS next Y9.41 Insider Trans-1.61% Shs Float109.71M Perf Month5.93%
Income850.00M PEG3.44 EPS next Q1.85 Inst Own91.15% Short Float2.41% Perf Quarter-3.25%
Sales9.25B P/S1.59 EPS this Y0.43% Inst Trans-1.35% Short Ratio2.56 Perf Half Y7.87%
Book/sh56.82 P/B2.34 EPS next Y7.60% ROA6.33% Short Interest2.65M Perf Year-4.09%
Cash/sh6.20 P/C21.48 EPS next 5Y5.17% ROE13.93% 52W Range119.59 - 148.62 Perf YTD-3.46%
Dividend Est.2.91 (2.19%) P/FCF17.06 EPS past 5Y7.36% ROI7.58% 52W High-10.44% Beta0.90
Dividend TTM2.84 (2.13%) Quick Ratio1.20 Sales past 5Y4.86% Gross Margin32.10% 52W Low11.31% ATR (14)2.16
Dividend Ex-DateApr 05, 2024 Current Ratio1.31 EPS Y/Y TTM-5.72% Oper. Margin14.76% RSI (14)65.78 Volatility1.33% 1.64%
Employees48000 Debt/Eq0.87 Sales Y/Y TTM-6.38% Profit Margin9.19% Recom2.40 Target Price142.35
Option/ShortYes / Yes LT Debt/Eq0.78 EPS Q/Q93.45% Payout37.76% Rel Volume0.86 Prev Close131.06
Sales Surprise1.53% EPS Surprise1.72% Sales Q/Q-1.93% EarningsFeb 01 BMO Avg Volume1.04M Price133.11
SMA204.11% SMA504.11% SMA2000.81% Trades Volume887,956 Change1.56%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Initiated Leerink Partners Market Perform $135
Feb-07-24Upgrade Jefferies Hold → Buy $140 → $155
Jan-03-24Initiated Barclays Equal Weight $145
Dec-12-23Upgrade BofA Securities Neutral → Buy $140 → $160
Jun-29-23Initiated Piper Sandler Neutral
May-02-23Downgrade BofA Securities Buy → Neutral $166 → $148
Apr-03-23Upgrade Citigroup Sell → Neutral $125 → $142
Jan-23-23Initiated Evercore ISI In-line $159
Nov-17-22Downgrade Citigroup Neutral → Sell $145 → $125
Aug-22-22Resumed Morgan Stanley Equal-Weight $142
Mar-26-24 12:30PM
07:09AM
Mar-20-24 11:15AM
Mar-19-24 03:06PM
Mar-14-24 01:20PM
01:45PM Loading…
Mar-06-24 01:45PM
Mar-05-24 12:15PM
Mar-04-24 02:45PM
Mar-01-24 09:36AM
Feb-29-24 01:45PM
Feb-27-24 02:30PM
12:19PM
Feb-24-24 12:06AM
Feb-23-24 11:24PM
11:30AM
09:35AM Loading…
09:35AM
Feb-21-24 12:00PM
Feb-15-24 07:58AM
06:00AM
Feb-13-24 08:16AM
08:07AM
Feb-12-24 08:01AM
Feb-06-24 07:14AM
Feb-05-24 07:17PM
Feb-02-24 10:10AM
Feb-01-24 10:56PM
06:06PM
12:58PM
09:30AM
09:27AM
07:55AM Loading…
07:55AM
07:11AM
06:45AM
Jan-31-24 02:50PM
Jan-29-24 12:45PM
Jan-26-24 04:07PM
09:15AM
Jan-22-24 08:07AM
Jan-19-24 07:25AM
Jan-18-24 07:18AM
05:04AM
Jan-17-24 09:35AM
08:58AM
Jan-15-24 07:46AM
05:02AM
Jan-10-24 09:40AM
Jan-09-24 01:01PM
08:05AM
Jan-08-24 08:56AM
07:07AM
Jan-04-24 10:00AM
Jan-03-24 01:45PM
Dec-21-23 01:04PM
Dec-20-23 07:34AM
07:01AM
Dec-19-23 10:45AM
08:54AM
Dec-18-23 10:30AM
07:47AM
Dec-14-23 08:53AM
Dec-13-23 03:15PM
Dec-11-23 10:15AM
Dec-08-23 07:25AM
Dec-07-23 01:50PM
08:01AM
Dec-06-23 09:04AM
Dec-05-23 02:30PM
Dec-01-23 03:10PM
Nov-30-23 07:28AM
Nov-29-23 11:33AM
Nov-28-23 09:30AM
08:40AM
Nov-27-23 12:45PM
09:08AM
Nov-23-23 11:30AM
Nov-22-23 10:38AM
Nov-21-23 11:15AM
Nov-20-23 08:52AM
Nov-15-23 01:30PM
Nov-13-23 06:00PM
02:30PM
10:34AM
Nov-11-23 07:00AM
Nov-09-23 03:30PM
08:45AM
Nov-08-23 09:15AM
Nov-06-23 11:55AM
Nov-05-23 01:28AM
Nov-03-23 07:25PM
Nov-01-23 12:15PM
Oct-30-23 04:50PM
Oct-26-23 08:05AM
Oct-25-23 11:42AM
10:21AM
07:00AM
Oct-24-23 11:05PM
11:42AM
10:45AM
09:40AM
09:30AM
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PREVOZNIK MICHAEL ESVP & General CounselFeb 29 '24Sale125.885,611706,31338,478Mar 01 04:50 PM
Doherty Catherine T.EVP, Regional BusinessesFeb 29 '24Sale125.881,187149,42068,412Mar 01 04:51 PM
Doherty Catherine T.EVP, Regional BusinessesFeb 28 '24Sale126.575,557703,34969,599Mar 01 04:51 PM
Gregg Vicky BDirectorFeb 23 '24Sale126.642,500316,59616,329Feb 23 04:34 PM
Doherty Catherine T.EVP, Regional BusinessesFeb 22 '24Sale126.14821103,56170,800Feb 23 04:32 PM
PREVOZNIK MICHAEL ESVP & General CounselFeb 22 '24Sale126.1466183,37940,206Feb 23 04:35 PM